Fortress Biotech (FBIO) EBIAT: 2013-2025
Historic EBIAT for Fortress Biotech (FBIO) over the last 13 years, with Sep 2025 value amounting to $8.8 million.
- Fortress Biotech's EBIAT rose 133.07% to $8.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$26.7 million, marking a year-over-year increase of 78.39%. This contributed to the annual value of -$120.9 million for FY2024, which is 21.60% up from last year.
- Fortress Biotech's EBIAT amounted to $8.8 million in Q3 2025, which was down 43.00% from $15.5 million recorded in Q2 2025.
- Over the past 5 years, Fortress Biotech's EBIAT peaked at $15.5 million during Q2 2025, and registered a low of -$68.5 million during Q4 2021.
- For the 3-year period, Fortress Biotech's EBIAT averaged around -$25.0 million, with its median value being -$26.7 million (2024).
- As far as peak fluctuations go, Fortress Biotech's EBIAT tumbled by 234.35% in 2021, and later spiked by 153.73% in 2025.
- Fortress Biotech's EBIAT (Quarterly) stood at -$68.5 million in 2021, then grew by 16.15% to -$57.4 million in 2022, then surged by 49.54% to -$29.0 million in 2023, then grew by 9.21% to -$26.3 million in 2024, then skyrocketed by 133.07% to $8.8 million in 2025.
- Its EBIAT stands at $8.8 million for Q3 2025, versus $15.5 million for Q2 2025 and -$24.7 million for Q1 2025.